Faculty of Pharmacy- University of Kufa held a symposium”Drug Target Discovery using Artificial Intelligence”.
It aimed to introduce the latest applications of artificial intelligence used in drug target identification and its application in the discovery of FB1006, which is still in the clinical trials and research stages.
It included:
-A review of traditional drug discovery methods and new methods using artificial intelligence
-The importance of deep learning in analyzing patient data in ALS
-Following the development stages of the drug FB1006, which has now reached the second phase of clinical trials and was designed entirely using artificial intelligence.
